- Home
- LND vs IGMS Comparison
LND vs IGMS Comparison
Compare LND & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LND
- IGMS
- Stock Information
- Founded
- LND 2005
- IGMS 1993
- Country
- LND Brazil
- IGMS United States
- Employees
- LND N/A
- IGMS N/A
- Industry
- LND Farming/Seeds/Milling
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- LND Consumer Staples
- IGMS Health Care
- Exchange
- LND Nasdaq
- IGMS Nasdaq
- Market Cap
- LND 360.6M
- IGMS 348.5M
- IPO Year
- LND 2006
- IGMS 2019
- Fundamental
- Price
- LND $3.82
- IGMS $1.54
- Analyst Decision
- LND
- IGMS Hold
- Analyst Count
- LND 0
- IGMS 8
- Target Price
- LND N/A
- IGMS $6.14
- AVG Volume (30 Days)
- LND 34.6K
- IGMS 910.9K
- Earning Date
- LND 02-06-2025
- IGMS 03-06-2025
- Dividend Yield
- LND 6.54%
- IGMS N/A
- EPS Growth
- LND 13.87
- IGMS N/A
- EPS
- LND 0.54
- IGMS N/A
- Revenue
- LND $216,814,626.00
- IGMS $2,918,000.00
- Revenue This Year
- LND $55.76
- IGMS $26.85
- Revenue Next Year
- LND N/A
- IGMS $125.17
- P/E Ratio
- LND $7.19
- IGMS N/A
- Revenue Growth
- LND N/A
- IGMS 57.64
- 52 Week Low
- LND $3.52
- IGMS $1.37
- 52 Week High
- LND $5.20
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- LND 49.20
- IGMS 19.44
- Support Level
- LND $3.80
- IGMS $1.37
- Resistance Level
- LND $3.93
- IGMS $1.59
- Average True Range (ATR)
- LND 0.07
- IGMS 0.16
- MACD
- LND 0.02
- IGMS 0.19
- Stochastic Oscillator
- LND 46.43
- IGMS 11.67
About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)
Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.